Skip Navigation


Mutagenesis Advance Access originally published online on April 4, 2007
Mutagenesis 2007 22(4):247-253; doi:10.1093/mutage/gem009
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
22/4/247    most recent
gem009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Google Scholar
Right arrow Articles by Jacinto, F. V.
Right arrow Articles by Esteller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacinto, F. V.
Right arrow Articles by Esteller, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author 2007. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Mutator pathways unleashed by epigenetic silencing in human cancer

Filipe V. Jacinto and Manel Esteller*

Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain

Human cancers exhibit genomic instability and an increased mutation rate due to underlying defects in DNA repair genes. Hypermethylation of CpG islands in gene promoter regions is an important mechanism of gene inactivation in cancer. Many cellular pathways, including DNA repair, are inactivated by this type of epigenetic lesion, resulting in mutator pathways. In this review, we discuss the adverse consequences suffered by a cell when DNA repair genes such as the DNA mismatch repair gene hMLH1, the DNA alkyl-repair gene O6-methylguanine-DNA methyltransferase, the familial breast cancer gene BRCA1 and the Werner syndrome gene WRN become epigenetically silenced in human cancer.

* To whom correspondence should be addressed. Tel: 34 91 2246940; Fax: 34 91 2246923; Email: mesteller{at}cnio.es

Received on January 3, 2007; revised on February 2, 2007; accepted on February 5, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. F. Rosati, R. F. Williams, L. C. Nunnally, M. C. McGee, T. L. Sims, L. Tracey, J. Zhou, M. Fan, C. Y. Ng, A. C. Nathwani, et al.
IFN-{beta} sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression
Mol. Cancer Ther., December 1, 2008; 7(12): 3852 - 3858.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Ashworth
A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
J. Clin. Oncol., August 1, 2008; 26(22): 3785 - 3790.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
Y. Zhao and R. J. Epstein
Programmed Genetic Instability: A Tumor-Permissive Mechanism for Maintaining the Evolvability of Higher Species through Methylation-Dependent Mutation of DNA Repair Genes in the Male Germ Line
Mol. Biol. Evol., August 1, 2008; 25(8): 1737 - 1749.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
F. L. Martin
Epigenomics and disease, 10th anniversary winter meeting of the UK Molecular Epidemiology Group (MEG), The Royal Statistical Society, London, UK, 8th December 2006
Mutagenesis, November 1, 2007; 22(6): 425 - 427.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.